MARKET

BIS

BIS

ProShares UltraShort Nasdaq Biotech
NASDAQ

Real-time Quotes | Provided by Morningstar

26.63
-1.74
-6.13%
Closed 13:00 11/27 EST
OPEN
27.96
PREV CLOSE
28.37
HIGH
27.96
LOW
26.60
VOLUME
41.05K
TURNOVER
--
52 WEEK HIGH
79.40
52 WEEK LOW
26.60
TOTAL ASSET
14.64M
YTD YIELD
-35.86%
1D
5D
1M
3M
1Y
5Y
News
Performance
Saudi Wealth Fund Making Another Splash, This Time at Home
Bloomberg · 11/17 14:58
Traders Shorting VIX Spur Inflows to $1.2 Billion Fund Down 34%
Bloomberg · 11/17 13:04
Saudi Wealth Fund Cuts U.S. Stock Holdings, Holds On to Uber
Bloomberg · 11/17 05:21
Tesla Is So Huge It May Take Two Steps to Put It in the S&P 500
Bloomberg · 11/17 00:09
Hedge Funds Bet on Tech Ahead of Unpredictable Fourth Quarter
Bloomberg · 11/16 23:08
A $1.3 Billion Leveraged Bet Against Tech Sees Record Outflows
Bloomberg · 11/16 16:52
Cathie Wood’s Ark Invest Rocked as Shareholder Seeks Control
A fight for control has broken out at one of the biggest success stories in the exchange-traded fund world this year.
Bloomberg · 11/16 15:48
Turkey’s Currency-Battered Stocks Have Been Luring U.S. Investors
Bloomberg · 11/16 12:46
More
No Data
Learn about the latest financial forecast of BIS. Analyze the recent business situations of ProShares UltraShort Nasdaq Biotech through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Month
11.9342%
--
3-Month
-1.3857%
--
6-Month
-38.6393%
--
1-Year
-35.8612%
--
3-Year
-24.4350%
--
5-Year
-22.8571%
--
10-Year
-39.5661%
--
Since Inception
-37.6429%
--
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
Profile
Fund Name
ProShares UltraShort Nasdaq Biotech
Risk
Low risk
Inception Date
2010-04-06
Benchmark
Russell 1000 Growth TR
Advisor Company
ProShares
Custodian
JPMorgan
Manager
Neches/Dave